Wirth MP - Search Results

1

Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.

Kraemer K, Fuessel S, Schmidt U, Kotzsch M, Schwenzer B, Wirth MP, Meye A. Kraemer K, et al. Among authors: wirth mp. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3794-800. Clin Cancer Res. 2003. PMID: 14506173

2

Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.

Pilarsky CP, Schmidt U, Eissrich C, Stade J, Froschermaier SE, Haase M, Faller G, Kirchner TW, Wirth MP. Pilarsky CP, et al. Among authors: wirth mp. Prostate. 1998 Jul 1;36(2):85-91. doi: 10.1002/(sici)1097-0045(19980701)36:2<85::aid-pros3>3.0.co;2-d. Prostate. 1998. PMID: 9655260

3

Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1.

Schmidt U, Fiedler U, Pilarsky CP, Ehlers W, Füssel S, Haase M, Faller G, Sauter G, Wirth MP. Schmidt U, et al. Among authors: wirth mp. Prostate. 2001 May 1;47(2):91-101. doi: 10.1002/pros.1051. Prostate. 2001. PMID: 11340631

4

Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro.

Schindler A, Fiedler U, Meye A, Schmidt U, Füssel S, Pilarsky C, Herrmann J, Wirth MP. Schindler A, et al. Among authors: wirth mp. Int J Oncol. 2001 Jul;19(1):25-30. Int J Oncol. 2001. PMID: 11408918

5

LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.

Fiedler U, Ehlers W, Meye A, Füssel S, Faller G, Schmidt U, Wirth MP. Fiedler U, et al. Among authors: wirth mp. Anticancer Res. 2001 Jul-Aug;21(4A):2341-50. Anticancer Res. 2001. PMID: 11724291

6

Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.

Meye A, Bilkenroth U, Schmidt U, Füssel S, Robel K, Melchior AM, Blümke K, Pinkert D, Bartel F, Linne C, Taubert H, Wirth MP. Meye A, et al. Among authors: wirth mp. Int J Oncol. 2002 Sep;21(3):521-30. Int J Oncol. 2002. PMID: 12168095

7

Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients.

Kiessling A, Schmitz M, Stevanovic S, Weigle B, Hölig K, Füssel M, Füssel S, Meye A, Wirth MP, Rieber EP. Kiessling A, et al. Among authors: wirth mp. Int J Cancer. 2002 Dec 1;102(4):390-7. doi: 10.1002/ijc.10713. Int J Cancer. 2002. PMID: 12402309

8

Tissue specific expression and serum levels of human tissue factor in patients with urological cancer.

Förster Y, Meye A, Albrecht S, Kotzsch M, Füssel S, Wirth MP, Schwenzer B. Förster Y, et al. Among authors: wirth mp. Cancer Lett. 2003 Apr 10;193(1):65-73. doi: 10.1016/s0304-3835(02)00687-0. Cancer Lett. 2003. PMID: 12691825

9

Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.

Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A, Wirth MP. Fuessel S, et al. Among authors: wirth mp. Int J Oncol. 2003 Jul;23(1):221-8. Int J Oncol. 2003. PMID: 12792797

10

Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.

Kiessling A, Füssel S, Schmitz M, Stevanovic S, Meye A, Weigle B, Klenk U, Wirth MP, Rieber EP. Kiessling A, et al. Among authors: wirth mp. Prostate. 2003 Sep 1;56(4):270-9. doi: 10.1002/pros.10265. Prostate. 2003. PMID: 12858355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters